Roche Holding AG
RHHBF
$335.90
$19.606.20%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 71.13B | 68.88B | 68.74B | 67.63B | 66.29B |
| Total Other Revenue | 2.19B | 2.14B | 2.16B | 2.10B | 2.03B |
| Total Revenue | 73.32B | 71.02B | 70.90B | 69.73B | 68.32B |
| Cost of Revenue | 18.48B | 17.92B | 17.88B | 17.67B | 17.40B |
| Gross Profit | 54.84B | 53.11B | 53.02B | 52.06B | 50.92B |
| SG&A Expenses | 15.94B | 15.51B | 15.54B | 15.32B | 15.05B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 270.95M | 151.11M | 11.54M | 251.63M | 488.99M |
| Total Operating Expenses | 49.88B | 48.56B | 48.63B | 48.42B | 48.03B |
| Operating Income | 23.44B | 22.46B | 22.26B | 21.31B | 20.29B |
| Income Before Tax | 15.24B | 13.98B | 13.35B | 14.08B | 14.80B |
| Income Tax Expenses | 3.28B | 3.06B | 2.96B | 2.40B | 1.84B |
| Earnings from Continuing Operations | 11.96K | 10.92K | 10.39K | 11.68K | 12.95K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.03B | -1.02B | -1.03B | -1.01B | -984.54M |
| Net Income | 10.93B | 9.90B | 9.36B | 10.67B | 11.97B |
| EBIT | 23.44B | 22.46B | 22.26B | 21.31B | 20.29B |
| EBITDA | 27.08B | 25.99B | 25.79B | 24.79B | 23.72B |
| EPS Basic | 13.73 | 12.43 | 11.74 | 13.38 | 15.00 |
| Normalized Basic EPS | 15.99 | 15.20 | 14.96 | 14.34 | 13.67 |
| EPS Diluted | 13.61 | 12.33 | 11.65 | 13.30 | 14.92 |
| Normalized Diluted EPS | 15.87 | 15.10 | 14.87 | 14.25 | 13.58 |
| Average Basic Shares Outstanding | 3.19B | 3.19B | 3.19B | 3.19B | 3.19B |
| Average Diluted Shares Outstanding | 3.21B | 3.21B | 3.21B | 3.21B | 3.21B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 82.22% | 86.17% | 91.97% | 80.65% | 71.88% |